TickerFacts.

Rafael Holdings, Inc. (RFL): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$288.0K
Year ended 2025-07-31
$203.0K
Trailing 12 months to 2026-04-30
+58.7%
3-year compound annual growth
-31.2%
5-year compound annual growth
$1.87M2016-07-31: $1.64M2017-07-31: $1.67M2018-07-31: $1.70M2019-07-31: $1.78M2020-07-31: $1.87M2021-07-31: $70.0K2022-07-31: $72.0K2023-07-31: $78.0K2024-07-31: $225.0K2025-07-31: $288.0K$288.0K
2016-07-31 Depreciation & Amortization (USD) 2025-07-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-07-31$288.0K+28.0%2025-10-29, From 2024-08-01
2024-07-31$225.0K+188.5%2025-10-29, From 2023-08-01
2023-07-31$78.0K+8.3%2024-12-20, From 2022-08-01
2022-07-31$72.0K+2.9%2023-10-30, From 2021-08-01
2021-07-31$70.0K-96.2%2022-10-31, From 2020-08-01
2020-07-31$1.87M+4.9%2021-10-18, From 2019-08-01
2019-07-31$1.78M+4.8%2020-10-29, From 2018-08-01
2018-07-31$1.70M+1.7%2019-10-04, From 2017-08-01
2017-07-31$1.67M+1.6%2018-10-15, From 2016-08-01
2016-07-31$1.64Mn/a2018-10-15, From 2015-08-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Rafael Holdings, Inc. (RFL)2025-07-31$288.0K+28.0%
Rallybio Corp (RLYB)2025-12-31$92.0K-29.8%
Shattuck Labs, Inc. (STTK)2025-12-31$3.70M-2.6%
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$43.3K+269.5%
Dare Bioscience, Inc. (DARE)2025-12-31$1.63Mn/m
Onconetix, Inc. (ONCO)2025-12-31$15.2K-97.9%
Hyperion Defi, Inc. (HYPD)2024-12-31$1.13M+44.1%
China SXT Pharmaceuticals, Inc. (SXTC)2026-03-31$73.7K-10.5%
Neuphoria Therapeutics Inc. (NEUP)2026-06-30$663.0K0.0%

Compare RFL, RLYB, STTK, SXTP side by side · Screen every company in Pharmaceutical Preparations ↗